TY  - JOUR
AU  - Lelpo, Benedetto
AU  - Caruso, Riccardo
AU  - Duran, Hipolito
AU  - Diaz, Eduardo
AU  - Fabra, Isabel
AU  - Malavé, Luis
AU  - Ferri, Valentina
AU  - Alvarez, Rafael
AU  - Cubillo, Antonio
AU  - Plaza Hernández, José Carlos
AU  - Lazzaro, Sara
AU  - Kalivaci, Denis
AU  - Quijano, Yolanda
AU  - Vicente, Emilio
PY  - 2017
DO  - 10.1016/J.SURONC.2017.08.003
UR  - https://hdl.handle.net/20.500.14352/117569
T2  - Surgical Oncology
AB  - Introduction Neoadjuvant treatment has been reported to prolong survival in patients with potentially resectable pancreatic adenocarcinoma (PA). However, there are currently limited clinical results available using nab-paclitaxel and gemcitabine in...
LA  - eng
M2  - 402
PB  - Elsevier
KW  - Pancreatic cancer
KW  - Pancreatectomy
KW  - Neoadjuvant treatment
TI  - A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma
TY  - journal article
VL  - 26
ER  -